Clinical trial
Phase I Trial of Oral Capecitabine Combined With 131I-huA33 in Patients With Metastatic Colorectal Cancer
NCT00291486 is registered in ClinicalTrials.gov with Ludwig Institute for Cancer Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Trial of Oral Capecitabine Combined With 131I-huA33 in Patients With Metastatic Colorectal Cancer
- Lead sponsor
- Ludwig Institute for Cancer Research
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- August 29, 2012
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.